These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 7729689)

  • 41. Identification of singles bar as a direct transcriptional target of Drosophila Myocyte enhancer factor-2 and a regulator of adult myoblast fusion.
    Brunetti TM; Fremin BJ; Cripps RM
    Dev Biol; 2015 May; 401(2):299-309. PubMed ID: 25797154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation.
    Maeda T; Chapman DL; Stewart AF
    J Biol Chem; 2002 Dec; 277(50):48889-98. PubMed ID: 12376544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. D-mef2 is a target for Tinman activation during Drosophila heart development.
    Gajewski K; Kim Y; Lee YM; Olson EN; Schulz RA
    EMBO J; 1997 Feb; 16(3):515-22. PubMed ID: 9034334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.
    Edmondson DG; Lyons GE; Martin JF; Olson EN
    Development; 1994 May; 120(5):1251-63. PubMed ID: 8026334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A role for nautilus in the differentiation of muscle precursors.
    Keller CA; Grill MA; Abmayr SM
    Dev Biol; 1998 Oct; 202(2):157-71. PubMed ID: 9769169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. zfh-1, the Drosophila homologue of ZEB, is a transcriptional repressor that regulates somatic myogenesis.
    Postigo AA; Ward E; Skeath JB; Dean DC
    Mol Cell Biol; 1999 Oct; 19(10):7255-63. PubMed ID: 10490660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventral neuroblasts and the heartless FGF receptor are required for muscle founder cell specification in Drosophila.
    Schulz RA; Gajewski K
    Oncogene; 1999 Nov; 18(48):6818-23. PubMed ID: 10597291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MEF2B is a potent transactivator expressed in early myogenic lineages.
    Molkentin JD; Firulli AB; Black BL; Martin JF; Hustad CM; Copeland N; Jenkins N; Lyons G; Olson EN
    Mol Cell Biol; 1996 Jul; 16(7):3814-24. PubMed ID: 8668199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The myogenic repressor gene Holes in muscles is a direct transcriptional target of Twist and Tinman in the Drosophila embryonic mesoderm.
    Elwell JA; Lovato TL; Adams MM; Baca EM; Lee T; Cripps RM
    Dev Biol; 2015 Apr; 400(2):266-76. PubMed ID: 25704510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive autoregulation of the Myocyte enhancer factor-2 myogenic control gene during somatic muscle development in Drosophila.
    Cripps RM; Lovato TL; Olson EN
    Dev Biol; 2004 Mar; 267(2):536-47. PubMed ID: 15013812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell lineages during mouse embryogenesis.
    Subramanian SV; Nadal-Ginard B
    Mech Dev; 1996 Jun; 57(1):103-12. PubMed ID: 8817457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage.
    Breitbart RE; Liang CS; Smoot LB; Laheru DA; Mahdavi V; Nadal-Ginard B
    Development; 1993 Aug; 118(4):1095-106. PubMed ID: 8269842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Muscle founder cells regulate defasciculation and targeting of motor axons in the Drosophila embryo.
    Landgraf M; Baylies M; Bate M
    Curr Biol; 1999 Jun; 9(11):589-92. PubMed ID: 10359699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.
    Yu YT; Breitbart RE; Smoot LB; Lee Y; Mahdavi V; Nadal-Ginard B
    Genes Dev; 1992 Sep; 6(9):1783-98. PubMed ID: 1516833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo.
    Anderson JP; Dodou E; Heidt AB; De Val SJ; Jaehnig EJ; Greene SB; Olson EN; Black BL
    Mol Cell Biol; 2004 May; 24(9):3757-68. PubMed ID: 15082771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expression of the myocyte enhancer factor 2 family of transcription factors in development: the cardiac factor BBF-1 is an early marker for cardiogenesis.
    Goswami S; Qasba P; Ghatpande S; Carleton S; Deshpande AK; Baig M; Siddiqui MA
    Mol Cell Biol; 1994 Aug; 14(8):5130-8. PubMed ID: 8035795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The CACC box and myocyte enhancer factor-2 sites within the myosin light chain 2 slow promoter cooperate in regulating nerve-specific transcription in skeletal muscle.
    Esser K; Nelson T; Lupa-Kimball V; Blough E
    J Biol Chem; 1999 Apr; 274(17):12095-102. PubMed ID: 10207035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis.
    Kuisk IR; Li H; Tran D; Capetanaki Y
    Dev Biol; 1996 Feb; 174(1):1-13. PubMed ID: 8626009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors.
    Molkentin JD; Olson EN
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9366-73. PubMed ID: 8790335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myocyte enhancer factor 2 (MEF2).
    Brand NJ
    Int J Biochem Cell Biol; 1997 Dec; 29(12):1467-70. PubMed ID: 9570140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.